Largest ever genetic study marks likely osteoporosis treatment target

September 5, 2017
Credit: CC0 Public Domain

Scientists are homing in on a potential treatment for osteoporosis, after performing the largest ever genetic study of the common age-related bone-thinning disease.

Researchers from The University of Queensland and McGill University in Canada led the study, identifying 153 new gene variants associated with the loss of bone mineral density, which often result in fractures.

UQ Diamantina Institute researchers Dr John Kemp and Professor David Evans found a strongly implicated gene GPC6, which had not previously been linked to .

"What makes this gene particularly interesting is that it encodes a protein that is present on the surface of cells, making it a potential candidate for a drug target," Professor Evans said.

"Our studies show that removing it in animal models resulted in an increase in bone thickness."

One in 10 Australians aged over 50 have osteoporosis or low bone mineral density, and the is more common in women than in men.

Associate Professor J. Brent Richards from McGill University said there is a strong inherited component with bone health, but osteoporosis often goes undetected until a fracture occurs.

"In 8540 participants who reported previous fractures from simple falls, associations were made with 12 of the new gene regions," Dr Richards said.

Credit: University of Queensland

The genome-wide association study involved more than 140,000 individuals from the UK Biobank, with density assessments taken from ultrasounds of the heel.

It triples the number of known to be implicated in the loss of , and the new gene variants account for 12 per cent of the heritability of the disease.

The results could be used to develop screening programs in the future to identify individuals who would benefit most from preventive measures.

A further study underway of half a million individuals is likely to shed more light on the genetics underlying the disease, and help prioritise genes most likely to lead to new treatments.

The research is published in Nature Genetics.

Explore further: Blood marker may predict postmenopausal women's risk of bone fractures

More information: John P Kemp et al. Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis, Nature Genetics (2017). DOI: 10.1038/ng.3949

Related Stories

Blood marker may predict postmenopausal women's risk of bone fractures

August 16, 2017
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral ...

Abaloparatide benefits a wide range of postmenopausal women with osteoporosis

September 19, 2016
A recent analysis of results from a randomized controlled clinical trial indicates that abaloparatide-SC, a novel therapy for osteoporosis, provides consistent protection against bone fractures in postmenopausal women with ...

Specific long-term therapy may not prevent fractures in older women

June 2, 2017
Osteoporosis is a disease that causes thinning of the bones, loss of bone density, and increasingly fragile bones. This puts people at higher risk for bone fractures. Risk for the disease increases as we age. In fact, 50% ...

Genes linked to osteoporosis, bone breaks

April 16, 2012
Researchers at The Institute for Aging Research at Hebrew SeniorLife, an affiliate of Harvard Medical School, have co-authored the largest meta-analysis of genome-wide association studies of osteoporosis as part of an international ...

Assessment of bone density and fracture history can predict long-term fracture risk

June 21, 2017
Factors such as low bone density and previous fractures are commonly used to predict an individual's risk of experiencing a fracture over the next 10 years. A new analysis has found that a single bone density measurement ...

Recommended for you

Scientists first to use genetic engineering technique to investigate Tourette's

September 25, 2017
Scientists at Rutgers University-New Brunswick are the first to use a genetic engineering technique to create brain cells from the blood cells of individuals in a three-generation family with Tourette syndrome to help determine ...

Newly revealed autism-related genes include genes involved in cancer

September 25, 2017
The identification of genes related to autism spectrum disorder (ASD) could help to better understand the disorder and develop new treatments. While scientists have found many genetic differences in different people with ...

Study reveals an ancient Achilles heel in the human genome

September 21, 2017
In a major study published today, researchers at deCODE genetics use whole-genome data from 14,000 people from across the population of Iceland, including 1500 sets of parents and children, to provide the most detailed portrait ...

Forgotten strands of DNA initiate the development of immune cells

September 21, 2017
Intricate human physiological features such as the immune system require exquisite formation and timing to develop properly. Genetic elements must be activated at just the right moment, across vast distances of genomic space.

Genome editing reveals role of gene important for human embryo development

September 20, 2017
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development. This is the first time that genome editing has been used to study gene function in human ...

A piece of the puzzle: Eight autism-related mutations in one gene

September 19, 2017
Scientists have identified a hotspot for autism-related mutations in a single gene.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.